Lethal Staphylococcus aureus-induced shock in primates: Prevention of death with anti-TNF antibody

Journal of Trauma - Injury, Infection and Critical Care

Volumn 33, Issue 4, 1992, Pages 568-573

  Hinshaw, Lerner B ^a   Emerson, Thomas E ^b   Taylor, Fletcher B ^a   Chang, Alvin C K ^c   Duerr, Melinda ^b   Peer, Glenn T ^c   Flournoy, Dale J ^d   White, Gary L ^c   Kosanke, Stanley D ^c   Murray, Cynthia K ^c   Xu, Robert ^c   Passey, Richard B ^e   Fournel, Michael A ^b  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b BAYER AG   (Germany)

^c UNIVERSITY OF OKLAHOMA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Oklahoma Memorial Hospital ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CEFTRIAXONE; CREATINE KINASE; CREATININE; ENDOTOXIN; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; HYDROCORTISONE; INTERLEUKIN 6; LACTIC ACID; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL PRESSURE; ARTICLE; BABOON; CONTROLLED STUDY; HEART RATE; HISTOPATHOLOGY; HYDROCORTISONE BLOOD LEVEL; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LACTATE BLOOD LEVEL; LEUKOCYTOSIS; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; SURVIVAL TIME; THROMBOCYTOPENIA; UREA NITROGEN BLOOD LEVEL;

ANIMAL; ANTIBODIES, MONOCLONAL; BLOOD COAGULATION; COLONY COUNT, MICROBIAL; INTERLEUKIN-6; PAPIO; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TUMOR NECROSIS FACTOR;

EID: 0026481128     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/00005373-199210000-00013     Document Type: Article

References (20)

1. Bone RC, Fisher CJ, Clemmer TP, et al: A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317:653, 1987
2. Hinshaw LB, Veterans Administration Study Group: Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 317:659, 1987
3. Hinshaw LB, Taylor FB Jr., Chang ACK, et al: Staphylococcus aureus-induced shock: A pathophysiologic study. Circ Shock 26:257, 1988
4. Mathison JC, Wolfson E, Ulevitch RJ: Participation of tumor necrosis factor in the mediation of gram-negative bacterial lipo-polysaccharide-induced injury in rabbits. J Clin Invest 81:1925, 1988
5. Michie HR, Manogue KR, Spriggs DR, et al: Detection of circulat ing tumor necrosis factor after endotoxin administration. N Engl J Med 318:1481, 1988
6. Tracey KJ, Fong Y, Hesse DG, et al: Anti-cachectin/TNF mono clonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662, 1987
7. Hinshaw LB, Tekamp-Olson P, Chang ACK, et al: Survival of primates in LDioo septic shock following therapy with antibody to tumor necrosis factor (TNFa). Circ Shock 30:279, 1990
8. Musher DM, McKenzie SO: Infections due to Staphylococcus au reus. Medicine 56:383, 1977
9. Sheagren JN: Staphylococcus aureus: The persistent pathogen. N Engl J Med 310:1368, 1984
10. Baud L, Cadronel J, Tenon H, et al: Tumor necrosis factor and septic shock. Crit Care Med 18:349, 1990
11. Marks JD, Marks CB, Luce JM, et al: Plasma tumor necrosis factor in patients with septic shock. Am Rev Respir Dis 141:94, 1990
12. Debets JMH, Kampmeijer R, van der Linden MPMH, et al: Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med 17:489, 1989
13. Hinshaw LB, Archer LT, Beller-Todd BK, et al: Survival of pri mates in LD10o septic shock following steroid/antibiotic therapy. J Surg Res 28:151, 1980
14. Hinshaw LB, Beller-Todd BK, Archer LT, et al: Effectiveness of steroid/antibiotic treatment in primates administered LDioo Escherichia coli. Ann Surg 194:51, 1981
15. Espevik T, Nissen-Meyer J: A highly sensitive cell line, WEHI164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immun Meth 95:99, 1986
16. Helle M, Boeije L, Aarden LA: Functional discrimination between interleukin 6 and interleukin 1. EurJ Immunol 18:1535, 1988
17. Fong Y, Moldawer LL, Marano M, et al: Endotoxemia elicits increased circulating /32-IFN/IL-6 in man. J Immunol 142:2321, 1989
18. Fong Y, Tracey KJ, Moldawer LL, et al: Antibodies to cachectin/ tumor necrosis factor reduce interleukin 1 0 and interleukin 6 appearance during lethal bacteremia. J Exp Med 170:1627, 1989
19. Wells CL, Maddaus MA, Simmons RL: Proposed mechanisms for the translocation of intestinal bacteria. Rev Infect Dis 10:958, 1988
20. Ziegler EJ, Fisher CJ, Sprung CL, et al: Treatment of gram- negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med 324:429, 1991s